Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
9 African migrants died in freezing temperatures near Morocco-Algeria border - 2The 15 Most Rousing TED Chats on Self-awareness
- 3Excited visitors for NASA's moon launch jockey for prime views
- 4International issues on the agenda as Frances's Macron visits China
- 5Visual communication Programming for Fledglings
- The most effective method to Pick the Right Teeth Substitution Choice for You
- More than 3 million eye drops have been recalled from CVS, Walgreens and other national retailers. How to check if yours are safe
- Genesis Marks 10th Anniversary With Magma GT Concept Aimed at High-Performance Flagships
- South Carolina confirms 124 new measles cases as outbreak on the Arizona-Utah line grows
- Doritos and Cheetos debut 'NKD' options, without artificial colors or flavors
- Proficient Cultivating Devices for a Lovely and Useful Nursery in 2024
- German petrol stations hike prices as once-a-day rule takes effect
- National health ranking puts Georgia near bottom of list. Here's why
- Artemis II astronauts will see parts of the moon no human has before. Here’s how
